CRBP - Corbus Pharmaceuticals Holdings, Inc.

NasdaqCM - NasdaqCM 即時價格。貨幣為 USD。
+0.60 (+6.76%)
收市:04:00PM EDT
9.28 -0.19 (-2.01%)
收市後: 05:55PM EDT
買盤9.36 x 1000
賣出價9.60 x 2900
今日波幅9.15 - 9.89
52 週波幅2.11 - 13.17
Beta 值 (5 年,每月)2.43
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-10.85
業績公佈日2023年8月07日 - 2023年8月11日
遠期股息及收益率無 (無)
1 年預測目標價71.00
  • Benzinga

    Corbus Pharma Expands Precision Oncology Pipeline With Addition Of Clinical-Stage Antibody Drug Conjugate

    Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) entered into an exclusive licensing agreement with CSPC Megalith Biopharmaceutical Co Ltd, a subsidiary of CSPC Pharmaceutical Group Limited, for the development and commercialization of CRB-701 (SYS6002), an antibody-drug conjugate targeting Nectin-4. The agreement covers exclusive commercialization rights to CRB-701 in the U.S., Canada, the European Union, the U.K., and Australia. The FDA has cleared the IND for CRB-701. CSPC is currently inve

  • Insider Monkey

    15 Best High Volume Penny Stocks to Buy Now

    In this article, we discuss the 15 best high volume penny stocks to buy now. If you want to read about some more high volume penny stocks, go directly to 5 Best High Volume Penny Stocks to Buy Now. Penny stocks had become an important indicator of the overall health of the stock market in […]